CLARITY PHARMACEUTICALS LTD

11.3%

$3.45

Market Cap $1.283B

Healthcare Biotechnology

Clarity Pharmaceuticals Ltd is an Australia-based clinical-stage radiopharmaceutical... Clarity Pharmaceuticals Ltd is an Australia-based clinical-stage radiopharmaceutical company. The Company is focused on developing theranostic (therapy and imaging) products, based on its platform SAR Technology. It is progressing seven clinical trials with its three key products, SARTATE, SAR-bisPSMA, and SAR-Bombesin. SARTATE is developed for diagnosing, staging, and treating cancers that express somatostatin receptor 2 (SSTR2), including neuroblastoma and neuroendocrine tumors (NETs). SAR-bisPSMA is developed for diagnosing, staging, and treating cancers that express Prostate Specific Membrane Antigen (PSMA). SAR-Bombesin is developed for identifying and selecting patients for subsequent treatment of cancers that express a specific receptor called the gastrin releasing peptide receptor (GRPr), including breast cancer and prostate cancer. It has a diverse range of products in clinical trials, which address both large indications as well as rare and orphan indications of cancer.More

Race Oncology (ASX: RAC) is an ASX-listed clinical stage biopharmaceutical company with a dedicated mission to be at the heart of cancer care. LATEST: Race Oncology Accelerates Game-Changing Cancer Drug.

Latest Threads

Tag

Subject

CU6

CU6 - ASX Charts

58 59 60

20/08/25

3.5K

1.3M

20/08/25

Last post longreach

3.5K

1.3M

CU6 Biotech

(Potential) short squeeze

5 6 7

20/08/25

385

121K

20/08/25

Last post NoGamblNoFuture

385

121K

CU6

Ann: Clarity successfully completes $203 million institutional pl

2 3

20/08/25

151

50K

20/08/25

Last post 24TIGES

151

50K

CU6

CU6 - Media and Industry News

22 23 24

18/08/25

1.3K

629K

18/08/25

Last post longreach

1.3K

629K

CU6

Price target up 34% to $9.....

16/08/25

8.5K

16/08/25

Last post ttppxx

8.5K

CU6

Ann: Cleansing Notice

11/08/25

331

11/08/25

Last post

ASX News

331

CU6

Ann: Application for quotation of securities - CU6

11/08/25

312

11/08/25

Last post

ASX News

312

CU6

Ann: Change in substantial holding

08/08/25

1.3K

08/08/25

Last post frenchfries57

1.3K

See All Discussions

Timeline

Cleansing Notice
11 Aug 10:53	Share

Application for quotation of securities - CU6
11 Aug 10:48	Share

Change in substantial holding
08 Aug 08:23	Share

Cleansing Notice
04 Aug 15:45	Share

Application for quotation of securities - CU6
04 Aug 15:43	Share

Notification regarding unquoted securities - CU6
04 Aug 09:46	Share

Ceasing to be a substantial holder
01 Aug 15:02	Share

Ceasing to be a substantial holder
01 Aug 15:00	Share

Ceasing to be a substantial holder
01 Aug 14:59	Share

Cleansing Notice
01 Aug 09:39	Share

Ceasing to be a substantial holder
31 Jul 16:16	Share

Quarterly Activities/Appendix 4C Cash Flow Report
31 Jul 11:57	Share

Application for quotation of securities - CU6
31 Jul 11:25	Share

Becoming a substantial holder
29 Jul 19:22	Share

Proposed issue of securities - CU6
28 Jul 09:44	Share

Clarity successfully completes $203 million institutional pl
28 Jul 09:42	Share

Change in substantial holding
24 Jul 08:18	Share

Co-PSMA trial recruitment successfully completed
17 Jul 09:45	Share

Notification of cessation of securities - CU6
14 Jul 15:47	Share

Cleansing Notice
04 Jul 10:41	Share

Application for quotation of securities - CU6
04 Jul 10:37	Share

Notice of initial substantial holder
04 Jul 09:12	Share

Change of Director's Interest Notice - M Parker
04 Jul 09:12	Share

Change of Director's Interest Notice - C Biggin
04 Jul 09:08	Share

Change of Director's Interest Notice - A Taylor
04 Jul 09:07	Share

Cleansing Notice
02 Jul 11:51	Share

Application for quotation of securities - CU6
02 Jul 11:48	Share

Change in substantial holding
01 Jul 08:27	Share

Cleansing Notice
24 Jun 09:35	Share

Application for quotation of securities - CU6
24 Jun 09:31	Share

View More

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $3.45		Change -0.440(11.3%)		Mkt cap ! $1.283B

Open	High	Low	Value	Volume
$3.78	$3.81	$3.43	$13.20M	3.725M

Buyers (Bids)

No.	Vol.	Price($)
2	11000	$3.45

Sellers (Offers)

Price($)	Vol.	No.
$3.48	2046	2

View Market Depth

No.	Vol.	Price($)
2	11000	3.450
3	55324	3.430
1	5000	3.420
3	7396	3.410
11	14747	3.400

Price($)	Vol.	No.
3.480	2046	2
3.490	24790	2
3.500	4000	1
3.530	2882	1
3.540	234	1

Last trade - 16.10pm 20/08/2025 (20 minute delay)


Last $3.46		Change -0.440 ( 11.2 %)
Open	High	Low	Volume
$3.80	$3.80	$3.44	514775
Last updated 15.59pm 20/08/2025 ?

CU6 (ASX) Chart

CLARITY PHARMACEUTICALS LTD

Latest Threads

Redcastle Resources (ASX:RC1): Strategic JV to Expedite Gold Production & Major Tenement Expansion in Eastern Goldfields

Timeline

Featured News

Latest Videos

Clarity Pharmaceuticals' (ASX:CU6) theranostic prostate cancer trial progresses to highest dose level

10 Aug 2023 12:13 (AEST)

Latest Articles

Clarity scribes deal on delivery of copper 64 isotopes

Clarity Pharmaceuticals Ltd has seen its share price leap after it announced a deal with Nusano to deliver Cu-64 isotopes

Another win for Clarity at FDA as imaging agent fast-tracked for complex prostate cancer

For those unlucky enough to have received a testicular castration to treat prostate cancer, only for it to come back, Clarity Pharmaceuticals’ (ASX:CU6) news on Wednesday morning could offer crucial moral support.For those patients (who have also already received first-stage less ...

Clarity jumps as FDA awards fast track status for PET scan imaging agent

Clarity Pharmaceuticals (ASX:CU6) has seen the U.S. FDA fast-track its prostate cancer imaging compound for use in PET scans on patients with recurring prostate cancer. The stock jumped 4% in the first hour of trade to $4.23 in what is likely a welcome move for shareholders who have already seen ...

Buyers (Bids)

Sellers (Offers)

Top Stories

Featured News